Jennifer Meessen

1.7k total citations
43 papers, 723 citations indexed

About

Jennifer Meessen is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Rheumatology. According to data from OpenAlex, Jennifer Meessen has authored 43 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 12 papers in Cardiology and Cardiovascular Medicine and 10 papers in Rheumatology. Recurrent topics in Jennifer Meessen's work include Sepsis Diagnosis and Treatment (7 papers), Heart Failure Treatment and Management (6 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Jennifer Meessen is often cited by papers focused on Sepsis Diagnosis and Treatment (7 papers), Heart Failure Treatment and Management (6 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Jennifer Meessen collaborates with scholars based in Italy, United States and Netherlands. Jennifer Meessen's co-authors include Roberto Latini, Rob G. H. H. Nelissen, Deborah Novelli, T. P. M. Vliet Vlieland, Francesco Vasques, Eleonora Duscio, Massimo Cressoni, Federica Romitti, Luciano Gattinoni and Michael Quintel and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Jennifer Meessen

41 papers receiving 715 citations

Peers

Countries citing papers authored by Jennifer Meessen

Since Specialization

Citations

This map shows the geographic impact of Jennifer Meessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Meessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Meessen more than expected).

Fields of papers citing papers by Jennifer Meessen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Meessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Meessen. The network helps show where Jennifer Meessen may publish in the future.

Co-authorship network of co-authors of Jennifer Meessen

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Meessen. A scholar is included among the top collaborators of Jennifer Meessen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Meessen. Jennifer Meessen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of calcium channel blockers on GDMT prescription and outcomes according to ejection fraction: IN-HF real world data 2025 ·European Journal of Internal Medicine ·Mauro Gori, (unknown), Jennifer Meessen, (unknown), Samuela Carigi, Matteo Bianco, Luisa De Gennaro, Concetta Di Nora, Paolo Manca, Maria Vittoria Matassini, Vittoria Rizzello, (unknown), Aldo P. Maggioni, Francesco Orso, Marco Gorini, Renata De Maria, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50% 2024 ·American Heart Journal ·(unknown), Ramin Shadman, Jeanne E. Poole, Todd Dardas, Donata Lucci, Jennifer Meessen, Roberto Latini, Aldo P. Maggioni, Wayne C. Levy	0
3	Ceramide and phosphatidylcholine lipids‐based risk score predicts major cardiovascular outcomes in patients with heart failure 2024 ·European Journal of Clinical Investigation ·(unknown), Jennifer Meessen, Mika Hilvo, Antti Jylhä, (unknown), (unknown), Patrick Rossignol, Deborah Novelli, Kévin Duarte, Giovanni Targher, Roberto Latini, Nicolas Girerd, Reijo Laaksonen	1
4	Amplitude Spectrum Area of ventricular fibrillation to guide defibrillation: a small open-label, pseudo-randomized controlled multicenter trial 2023 ·EBioMedicine ·Laura Ruggeri, Francesca Fumagalli, (unknown), Federico Semeraro, Jennifer Meessen, (unknown), Maurizio Migliari, Aurora Magliocca, Giovanni Gordini, Roberto Fumagalli, Giuseppe Maria Sechi, Antonio Pesenti, Markus B. Skrifvars, Yongqin Li, Roberto Latini, Lars Wik, Giuseppe Ristagno	9
5	Prognostic value of secretoneurin in chronic heart failure. Data from the GISSI-Heart Failure trial 2023 ·Clinical Biochemistry ·Helge Røsjø, Jennifer Meessen, (unknown), Roberto Latini, Torbjørn Omland	4
6	IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study 2021 ·BMC Cardiovascular Disorders ·Jennifer Meessen, Giulia Cesaroni, Gian Francesco Mureddu, Alessandro Boccanelli, Ursula‐Henrike Wienhues‐Thelen, Peter Kastner, Luisa Ojeda‐Fernández, Deborah Novelli, Gianfranco Bazzoni, Maurizio Mangiavacchi, Nera Agabiti, Serge Masson, Lidia Staszewsky, Roberto Latini, (unknown)	14
7	Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial 2021 ·Annals of Intensive Care ·Laura Alagna, Jennifer Meessen, Giacomo Bellani, (unknown), Pietro Caironi, (unknown), Luigi Vivona, Giacomo Grasselli, F. Motta, (unknown), Vieri Parrini, Stefano Romagnoli, Roberto Keim, (unknown), Fabio Silvio Taccone, (unknown), Barbara Bottazzi, Alessandra Bandera, Andrea Cortegiani, Roberto Latini	9
8	Comparison of physical activity among different subsets of patients with knee or hip osteoarthritis and the general population 2020 ·Rheumatology International ·(unknown), (unknown), Jennifer Meessen, W.F. Peter, T. P. M. Vliet Vlieland, (unknown), Job van der Palen, F.H.J. van den Hoogen, C.H.M. van den Ende	7
9	Identification and characterization of two consistent osteoarthritis subtypes by transcriptome and clinical data integration 2020 ·Lara D. Veeken ·Rodrigo Coutinho de Almeida, Ahmed Mahfouz, Hailiang Mei, E. Houtman, Wouter den Hollander, Jamie Soul, H. Eka D. Suchiman, Nico Lakenberg, Jennifer Meessen, (unknown), Rob G. H. H. Nelissen, Y.F. Ramos, Marcel Reinders, Ingrid Meulenbelt	24
10	Prospective Evaluation of Clinico-Pathological Predictors of Postoperative Atrial Fibrillation 2020 ·Circulation Arrhythmia and Electrophysiology ·Domenico Corradi, Jeffrey E. Saffitz, Deborah Novelli, (unknown), Caterina Simon, Emanuela Oldoni, Serge Masson, Jennifer Meessen, (unknown), (unknown), Roberto Latini, Peter Libby, Luigi Tavazzi, Roberto Marchioli, Luca Dozza, Laura Cavallotti, Aneta Aleksova, Renato Gregorini, Dariush Mozaffarian	9
11	Association of handgrip strength with patient-reported outcome measures after total hip and knee arthroplasty 2020 ·Rheumatology International ·Jennifer Meessen, Marta Fiocco, (unknown), (unknown), S. H. M. Verdegaal, P. Eline Slagboom, T. P. M. Vliet Vlieland, Rob G. H. H. Nelissen	5
12	Relation Between Plasma Ceramides and Cardiovascular Death in Chronic Heart Failure: A Subset Analysis of the GISSI-HF Trial 2020 ·ESC Heart Failure ·Giovanni Targher, (unknown), Alessandro Mantovani, Jennifer Meessen, Stefano Bonapace, Pier Luigi Temporelli, Enrico Nicolis, Deborah Novelli, Antonio Conti, Luigi Tavazzi, Aldo P. Maggioni, Roberto Latini	18
13	External applicability of the ISCHEMIA trial: an analysis of a prospective, nationwide registry of patients with stable coronary artery disease 2020 ·EuroIntervention ·Leonardo De Luca, Massimo Uguccioni, Jennifer Meessen, Pier Luigi Temporelli, Fabrizio Tomai, (unknown), Enrico Passamonti, (unknown), Carmine Riccio, Domenico Gabrielli, Furio Colivicchi, Michele Massimo Gulizia, Gian Piero Perna	13
14	Serum fatty acid chain length associates with prevalent symptomatic end-stage osteoarthritis, independent of BMI 2020 ·Scientific Reports ·Jennifer Meessen, Fatemeh Saberi Hosnijeh, Nils Bömer, Wouter den Hollander, Johanna G. van der Bom, J. A. van Hilten, W.E. van Spil, Cynthia So‐Osman, André G. Uitterlinden, M. Kloppenburg, Rob G. H. H. Nelissen, Cornelia M. van Duijn, P. Eline Slagboom, Joyce B. J. van Meurs, Ingrid Meulenbelt	9
15	Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registry 2020 ·International Journal of Cardiology ·Leonardo De Luca, Marcello Arca, Pier Luigi Temporelli, Jennifer Meessen, Carmine Riccio, (unknown), Angela Rita Colavita, Domenico Gabrielli, Michele Massimo Gulizia, Furio Colivicchi	19
16	Understanding Lactatemia in Human Sepsis. Potential Impact for Early Management 2019 ·American Journal of Respiratory and Critical Care Medicine ·Luciano Gattinoni, Francesco Vasques, Luigi Camporota, Jennifer Meessen, Federica Romitti, Iacopo Pasticci, Eleonora Duscio, Francesco Vassalli, Lui G. Forni, Didier Payen, Massimo Cressoni, Alberto Zanella, Roberto Latini, Michael Quintel, John J. Marini	100
17	sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T 2018 ·Journal of the American College of Cardiology ·Michele Emdin, Alberto Aimo, Giuseppe Vergaro, Antoni Bayés‐Genís, Josep Lupón, Roberto Latini, Jennifer Meessen, Inder S. Anand, Jay N. Cohn, Jørgen Gravning, Lars Gullestad, Kaspar Broch, Thor Ueland, Ståle H. Nymo, Hans‐Peter Brunner‐La Rocca, Rudolf A. de Boer, Hanna K. Gaggin, Andrea Ripoli, Claudio Passino, James L. Januzzi	130
18	Physical activity in patients with systemic sclerosis 2017 ·Rheumatology International ·(unknown), Jennifer Meessen, Ron Wolterbeek, Nina Ajmone Marsan, (unknown), T. P. M. Vliet Vlieland, Jeska K de Vries‐Bouwstra	17
19	Radiographic endophenotyping in hip osteoarthritis improves the precision of genetic association analysis 2016 ·Annals of the Rheumatic Diseases ·Kalliope Panoutsopoulou, Shankar Thiagarajah, Eleni Zengini, Aaron Day-Williams, Y.F. Ramos, Jennifer Meessen, (unknown), Rob G. H. H. Nelissen, Lorraine Southam, Nigel W. Rayner, Michael Doherty, Ingrid Meulenbelt, Eleftheria Zeggini, J. Mark Wilkinson, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	24
20	Increased Mortality in Metal-on-Metal versus Non-Metal-on-Metal Primary Total Hip Arthroplasty at 10 Years and Longer Follow-Up: A Systematic Review and Meta-Analysis 2016 ·PLoS ONE ·Bart G. Pijls, Jennifer Meessen, Jan W. Schoones, Marta Fiocco, Huub J. L. van der Heide, Art Sedrakyan, Rob G. H. H. Nelissen	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact